Early left atrial venting versus conventional treatment for left ventricular decompression during venoarterial extracorporeal membrane oxygenation support: The EVOLVE‐ECMO randomized clinical trial.

MLA

Park, Hanbit, et al. “Early Left Atrial Venting versus Conventional Treatment for Left Ventricular Decompression during Venoarterial Extracorporeal Membrane Oxygenation Support: The EVOLVE‐ECMO Randomized Clinical Trial.” European Journal of Heart Failure, vol. 25, no. 11, Nov. 2023, pp. 2037–46. EBSCOhost, https://doi.org/10.1002/ejhf.3014.

APA

Park, H., Yang, J. H., Ahn, J., Kang, D., Lee, P. H., Kim, T. O., Choi, K. H., Kang, P. J., Jung, S., Yun, S., Park, D., Lee, S., Park, S., & Kim, M. (2023). Early left atrial venting versus conventional treatment for left ventricular decompression during venoarterial extracorporeal membrane oxygenation support: The EVOLVE‐ECMO randomized clinical trial. European Journal of Heart Failure, 25(11), 2037–2046. https://doi.org/10.1002/ejhf.3014

Chicago

Park, Hanbit, Jeong Hoon Yang, Jung‐Min Ahn, Do‐Yoon Kang, Pil Hyung Lee, Tae Oh Kim, Ki Hong Choi, et al. 2023. “Early Left Atrial Venting versus Conventional Treatment for Left Ventricular Decompression during Venoarterial Extracorporeal Membrane Oxygenation Support: The EVOLVE‐ECMO Randomized Clinical Trial.” European Journal of Heart Failure 25 (11): 2037–46. doi:10.1002/ejhf.3014.